Jingfang Zhang

Jingfang Zhang

School of Life Sciences, Beijing University of Chinese Medicine

Affiliated withBeijing University of Chinese Medicine

Research Area

Biography

Jingfang Zhang has not added Biography.
If you are Jingfang Zhang and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
Publication title
2025

Other Publications

Article
Year
Discrimination of wild and domestic deer musk using isotope ratio mass spectrometry.

Journal of mass spectrometry : JMS| PubMed ID: 30120795

2018
Drug Inducible CRISPR/Cas Systems.

Computational and structural biotechnology journal| PubMed ID: 31462973

2019
[Discovery of cytochrome P450 enzymes-inhibiting components in traditional Chinese medicine].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica| PubMed ID: 32237495

2020
[A new lignan glucoside from root of Paeonia lactiflora].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica| PubMed ID: 32627465

2020
2020
2021
2021
2021
Bioactive neolignans and lignans from the roots of Paeonia lactiflora.

Chinese journal of natural medicines| PubMed ID: 35369965

2022
2023
2023
Development of a Nomogram That Predicts the Risk of Coronary Heart Disease in Patients With Hyperlipidemia.

Journal of cardiovascular pharmacology and therapeutics| PubMed ID: 37097005

2023
Repurposing CRISPR/Cas to Discover SARS-CoV-2 Detecting and Neutralizing Aptamers.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)| PubMed ID: 37204115

2023
2023
2024
Shexiang Baoxin Pill enriches Lactobacillus to regulate purine metabolism in patients with stable coronary artery disease.

Phytomedicine : international journal of phytotherapy and phytopharmacology| PubMed ID: 38781732

2024